Andrew Polovin sells Class A shares via 10b5‑1

Andrew Polovin reported sales of Class A Common Stock under 10b5‑1 transactions.

Rhea-AI Filing Summary

Andrew Polovin reported sales of Class A Common Stock under 10b5‑1 transactions. The filing lists two sales in November 2025: 6,387 shares on 11/19/2025 for $434,708.16 and 12,874 shares on 11/24/2025 for $965,550restricted stock unit awards with grant dates and share counts: 1,549 (04/27/2022), 527 (04/18/2023), 2,107 (07/18/2023), 703 (05/02/2024), and 3,257 (11/01/2024).

Insights

Securities Compliance Attorney

Form 144 shows executed 10b5‑1 sales and lists RSUs by grant date.

The entries record two completed 10b5‑1 sales by Andrew Polovin on 11/19/2025 (6,387 shares; $434,708.16) and 11/24/2025 (12,874 shares; $965,550).

The filing also itemizes several restricted stock units with grant dates and share counts, which are presented as securities related to the reporting person. Cash‑flow treatment and any issuer involvement are not stated in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sales did Andrew Polovin report in the Form 144 for TEM?

The filing shows two 10b5‑1 sales by Andrew Polovin: 6,387 shares on 11/19/2025 for $434,708.16 and 12,874 shares on 11/24/2025 for $965,550.

Does the Form 144 list restricted stock units for Andrew Polovin?

Yes. The notice lists RSUs with grant dates and counts: 1,549 (04/27/2022), 527 (04/18/2023), 2,107 (07/18/2023), 703 (05/02/2024), and 3,257 (11/01/2024).

Were the sales disclosed in the Form 144 executed under a trading plan?

The entries are described as 10b5‑1 Sales, indicating sales executed under a trading plan; the filing lists the dates and proceeds but does not include plan terms in the excerpt.

Which security class is referenced in the filing for TEM?

The filing references Class A Common Stock for both the 10b5‑1 sales and the listed restricted stock units; the exchange listed is NASDAQ in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 09:22 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002024169
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TEMPUS AI, INC.
SEC File Number	001-42130
Address of Issuer	600 WEST CHICAGO AVENUE, SUITE 510 CHICAGO ILLINOIS 60654
Phone	800-976-5448
Name of Person for Whose Account the Securities are To Be Sold	Andrew Polovin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	8143	457310.88	172863470	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	04/27/2022	Restricted Stock Units	Issuer			1549	04/27/2022	N/A
Class A Common Stock	04/18/2023	Restricted Stock Units	Issuer			527	04/18/2023	N/A
Class A Common Stock	07/18/2023	Restricted Stock Units	Issuer			2107	07/18/2023	N/A
Class A Common Stock	05/02/2024	Restricted Stock Units	Issuer			703	05/02/2024	N/A
Class A Common Stock	11/01/2024	Restricted Stock Units	Issuer			3257	11/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANDREW POLOVIN 600 WEST CHICAGO AVENUE, Suite 510 CHICAGO IL 60654	Class A Common Stock	11/19/2025	6387	434708.16
10b5-1 Sales for ANDREW POLOVIN 600 WEST CHICAGO AVENUE, Suite 510 CHICAGO IL 60654	Class A Common Stock	11/24/2025	12874	965550

144: Remarks and Signature

Remarks	The sales reported on this Form 144 are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by sell to cover transactions and do not represent discretionary trades by the reporting person.
Date of Notice	02/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew Polovin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)